Patient Access to Innovative New Technologies Act of 2024

Hozzl · 2024-12-19T09:05:57Z

Explore the details of House Bill 7939 Patient Access to Innovative New Technologies Act of 2024 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/19/2024, 9:05 AM

Summary of Bill HR 7939

Bill 118 HR 7939, also known as the Patient Access to Innovative New Technologies Act of 2024, aims to improve patient access to cutting-edge medical technologies. The bill focuses on streamlining the approval process for new medical devices and treatments, making it easier for patients to benefit from the latest advancements in healthcare.

One key aspect of the bill is the establishment of a new pathway for the approval of breakthrough medical technologies. This pathway will allow for expedited review and approval of innovative treatments that have the potential to significantly improve patient outcomes. By reducing regulatory barriers, the bill aims to ensure that patients have timely access to life-saving and life-improving technologies.

Additionally, the bill includes provisions to enhance transparency and communication between the FDA, healthcare providers, and patients. This will help ensure that patients are informed about the availability of new technologies and can make informed decisions about their healthcare options. Overall, the Patient Access to Innovative New Technologies Act of 2024 seeks to promote innovation in healthcare and improve patient access to the latest medical advancements. By streamlining the approval process and enhancing communication, the bill aims to ensure that patients can benefit from the most cutting-edge treatments available.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 7939

Bill HR 7939 is currently in the status of Bill Introduced since April 11, 2024. Bill HR 7939 was introduced during Congress 118 and was introduced to the House on April 11, 2024. Bill HR 7939's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 7939

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 7939

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 7939

Patient Access to Innovative New Technologies Act of 2024Patient Access to Innovative New Technologies Act of 2024To amend title XVIII of the Social Security Act to improve Medicare beneficiary access to new medical technologies that improve health care quality and outcomes by ensuring that breakthrough devices are eligible for conditional approval under the Medicare New Technology Add-On Payment (NTAP) Program, enabling these medical breakthroughs to be provided to Medicare beneficiaries without unnecessary delay.

Start holding our government accountable!

Comments

Sponsors and Cosponsors of HR 7939

Danny K. Davis

Illinois(Democrat)

Latest Bills